We offer high flexibility, technical expertise and experience to develop and produce your oral solid and sterile drug products.
Your development projects are eligible for the Research Tax Credit (CIR) up to 30% of the amount.
We have obtained the Research Tax Credit agreement from the French Ministry of Higher Education, Research and Innovation (MESRI) to execute R&D activities for third parties.
Our production systems meet current safety, environmental and quality standards, with recognized procedural knowledge in the development and manufacturing of tablets and micro-tablets.
We manage the development and manufacturing of injectables freeze-dried and liquid products in vials.
We manage primary and secondary packaging services in blisters, bottles